Article
Integrative bulk and single-cell transcriptomics identify a chemoresistance-related risk model for recurrence prediction in colorectal cancer
2026-02-17
Abstract excerpt
<title>Abstract</title> <p>Chemoresistance remains a major obstacle to improving outcomes in colorectal cancer (CRC), particularly among patients receiving 5-fluorouracil (5-FU)–based therapy. Here, we developed and validated a drug resistance–related gene signature to predict recurrence and treatment response in CRC. In the GSE190826 cohort, patients without pathological complete response (non-pCR) exhibited sig...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e74e9da6-af86-59e6-9867-b0b459da75dc
- DOI
- 10.21203/rs.3.rs-8797652/v1
